Literature DB >> 24504127

Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Vladimir V Bamm1, George Harauz.   

Abstract

Although iron is known to be essential for the normal development and health of the central nervous system, abnormal iron deposits are found in and around multiple sclerosis (MS) lesions that themselves are closely associated with the cerebral vasculature. However, the origin of this excess iron is unknown, and it is not clear whether this is one of the primary causative events in the pathogenesis of MS, or simply another consequence of the long-lasting inflammatory conditions. Here, applying a systems biology approach, we propose an additional way for understanding the neurodegenerative component of the disease caused by chronic subclinical extravasation of hemoglobin, in combination with multiple other factors including, but not limited to, dysfunction of different cellular protective mechanisms against extracellular hemoglobin reactivity and oxidative stress. Moreover, such considerations could also shed light on and explain the higher susceptibility of MS patients to a wide range of cardiovascular disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504127     DOI: 10.1007/s00018-014-1570-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  136 in total

Review 1.  Immunologic privilege in the central nervous system and the blood-brain barrier.

Authors:  Leslie L Muldoon; Jorge I Alvarez; David J Begley; Ruben J Boado; Gregory J Del Zoppo; Nancy D Doolittle; Britta Engelhardt; John M Hallenbeck; Russell R Lonser; John R Ohlfest; Alexandre Prat; Maurizio Scarpa; Richard J Smeyne; Lester R Drewes; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

2.  Association of smoking with risk of multiple sclerosis: a population-based study.

Authors:  Sreeram V Ramagopalan; Joshua D Lee; Irene M Yee; Colleen Guimond; Anthony L Traboulsee; George C Ebers; A Dessa Sadovnick
Journal:  J Neurol       Date:  2013-03-02       Impact factor: 4.849

Review 3.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.

Authors:  Sandro Altamura; Martina U Muckenthaler
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

4.  Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states.

Authors:  Peter Hahl; Taron Davis; Cecilia Washburn; Jack T Rogers; Ann Smith
Journal:  J Neurochem       Date:  2013-02-25       Impact factor: 5.372

Review 5.  Metabolic injury to axons and myelin.

Authors:  Shigeki Tsutsui; Peter K Stys
Journal:  Exp Neurol       Date:  2012-05-01       Impact factor: 5.330

6.  Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis.

Authors:  Mohit Neema; Ashish Arora; Brian C Healy; Zachary D Guss; Steven D Brass; Yang Duan; Guy J Buckle; Bonnie I Glanz; Lynn Stazzone; Samia J Khoury; Howard L Weiner; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2009-01       Impact factor: 2.486

7.  Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter.

Authors:  Meng Law; Amit M Saindane; Yulin Ge; James S Babb; Glyn Johnson; Lois J Mannon; Joseph Herbert; Robert I Grossman
Journal:  Radiology       Date:  2004-06       Impact factor: 11.105

8.  Vascular pathology in multiple sclerosis: mind boosting or myth busting?

Authors:  Anne Waschbisch; Arndt Manzel; Ralf A Linker; De-Hyung Lee
Journal:  Exp Transl Stroke Med       Date:  2011-07-14

9.  Pathoetiology of multiple sclerosis: are we barking up the wrong tree?

Authors:  Peter K Stys
Journal:  F1000Prime Rep       Date:  2013-06-03

10.  Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia.

Authors:  Beibei Dong; Min Cai; Zongping Fang; Haidong Wei; Fangyun Zhu; Guochao Li; Hailong Dong; Lize Xiong
Journal:  BMC Neurosci       Date:  2013-06-10       Impact factor: 3.288

View more
  11 in total

1.  Source of iron overload in multiple sclerosis.

Authors:  Diego Di Lorenzo; Giorgio Biasiotto; Isabella Zanella
Journal:  Cell Mol Life Sci       Date:  2014-05-16       Impact factor: 9.261

Review 2.  Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors:  Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal:  Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.590

Review 3.  Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.

Authors:  Meric A Altinoz; Emin M Ozcan; Bahri Ince; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2016-05-28       Impact factor: 3.584

Review 4.  Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.

Authors:  Vladimir V Bamm; Arielle M Geist; George Harauz
Journal:  Metab Brain Dis       Date:  2016-11-02       Impact factor: 3.584

Review 5.  Iron in multiple sclerosis: roles in neurodegeneration and repair.

Authors:  Erin Stephenson; Nabeela Nathoo; Yasamin Mahjoub; Jeff F Dunn; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

6.  Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study.

Authors:  Jose Enrique de la Rubia Ortí; Jose Luis Platero; María Benlloch; Lorena Franco-Martinez; Asta Tvarijonaviciute; Jesús Escribá-Alepuz; Sandra Sancho-Castillo
Journal:  Biomolecules       Date:  2021-04-21

Review 7.  Aspirin and multiple sclerosis.

Authors:  Sheila Tsau; Mitchell R Emerson; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2015-06-29       Impact factor: 8.775

Review 8.  New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.

Authors:  Bożena Adamczyk; Monika Adamczyk-Sowa
Journal:  Oxid Med Cell Longev       Date:  2016-10-18       Impact factor: 6.543

Review 9.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

10.  Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.

Authors:  Muhammed Emin Ozcan; Bahri Ince; Hasan Huseyin Karadeli; Asuman Gedikbasi; Talip Asil; Meric A Altinoz
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-16       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.